Literature DB >> 22744670

Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study.

R B Postuma1, J Y Montplaisir, A Pelletier, Y Dauvilliers, W Oertel, A Iranzo, L Ferini-Strambi, I Arnulf, B Hogl, R Manni, T Miyamoto, G Mayer, K Stiasny-Kolster, M Puligheddu, Y Ju, P Jennum, K Sonka, J Santamaria, M L Fantini, M Zucconi, S Leu-Semenescu, B Frauscher, M Terzaghi, M Miyamoto, M M Unger, V Cochen De Cock, C Wolfson.   

Abstract

OBJECTIVE: Idiopathic REM sleep behavior disorder is a parasomnia characterized by dream enactment and is commonly a prediagnostic sign of parkinsonism and dementia. Since risk factors have not been defined, we initiated a multicenter case-control study to assess environmental and lifestyle risk factors for REM sleep behavior disorder.
METHODS: Cases were patients with idiopathic REM sleep behavior disorder who were free of dementia and parkinsonism, recruited from 13 International REM Sleep Behavior Disorder Study Group centers. Controls were matched according to age and sex. Potential environmental and lifestyle risk factors were assessed via standardized questionnaire. Unconditional logistic regression adjusting for age, sex, and center was conducted to investigate the environmental factors.
RESULTS: A total of 694 participants (347 patients, 347 controls) were recruited. Among cases, mean age was 67.7 ± 9.6 years and 81.0% were male. Cases were more likely to smoke (ever smokers = 64.0% vs 55.5%, adjusted odds ratio [OR] = 1.43, p = 0.028). Caffeine and alcohol use were not different between cases and controls. Cases were more likely to report previous head injury (19.3% vs 12.7%, OR = 1.59, p = 0.037). Cases had fewer years of formal schooling (11.1 ± 4.4 years vs 12.7 ± 4.3, p < 0.001), and were more likely to report having worked as farmers (19.7% vs 12.5% OR = 1.67, p = 0.022) with borderline increase in welding (17.8% vs 12.1%, OR = 1.53, p = 0.063). Previous occupational pesticide exposure was more prevalent in cases than controls (11.8% vs 6.1%, OR = 2.16, p = 0.008).
CONCLUSIONS: Smoking, head injury, pesticide exposure, and farming are potential risk factors for idiopathic REM sleep behavior disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744670      PMCID: PMC3405255          DOI: 10.1212/WNL.0b013e31825dd383

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Adjusting for multiple testing--when and how?

Authors:  R Bender; S Lange
Journal:  J Clin Epidemiol       Date:  2001-04       Impact factor: 6.437

Review 2.  Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.

Authors:  Jean-François Gagnon; Ronald B Postuma; Stéphanie Mazza; Julien Doyon; Jacques Montplaisir
Journal:  Lancet Neurol       Date:  2006-05       Impact factor: 44.182

Review 3.  Occupational and environmental risk factors for Parkinson's disease.

Authors:  B C L Lai; S A Marion; K Teschke; J K C Tsui
Journal:  Parkinsonism Relat Disord       Date:  2002-06       Impact factor: 4.891

Review 4.  Visual hallucinations in Parkinson's disease: clues to separate origins.

Authors:  M Onofrj; L Bonanni; G Albani; A Mauro; D Bulla; A Thomas
Journal:  J Neurol Sci       Date:  2006-06-23       Impact factor: 3.181

5.  Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.

Authors:  Alex Iranzo; José Luis Molinuevo; Joan Santamaría; Mónica Serradell; María José Martí; Francesc Valldeoriola; Eduard Tolosa
Journal:  Lancet Neurol       Date:  2006-07       Impact factor: 44.182

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Education and dementia: a meta-analytic study.

Authors:  Francisco Caamaño-Isorna; Montserrat Corral; Agustín Montes-Martínez; Bahi Takkouche
Journal:  Neuroepidemiology       Date:  2006-05-16       Impact factor: 3.282

8.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Authors:  B F Boeve; M H Silber; J E Parisi; D W Dickson; T J Ferman; E E Benarroch; A M Schmeichel; G E Smith; R C Petersen; J E Ahlskog; J Y Matsumoto; D S Knopman; C H Schenck; M W Mahowald
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

9.  Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults.

Authors:  C H Schenck; S R Bundlie; A L Patterson; M W Mahowald
Journal:  JAMA       Date:  1987-04-03       Impact factor: 56.272

10.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

Authors:  C H Schenck; S R Bundlie; M W Mahowald
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

View more
  41 in total

Review 1.  [REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy].

Authors:  W H Oertel; C Depboylu; M Krenzer; D Vadasz; V Ries; F Sixel-Döring; G Mayer
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

2.  REM sleep behavior disorder: from epidemiology to heterogeneity.

Authors:  Siu Ping Lam; Jihui Zhang; Yun-Kwok Wing
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

Review 3.  Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.

Authors:  Daniel A Barone; Claire Henchcliffe
Journal:  Clin Neurophysiol       Date:  2018-05-29       Impact factor: 3.708

4.  Long-Term Follow-up Investigation of Isolated Rapid Eye Movement Sleep Without Atonia Without Rapid Eye Movement Sleep Behavior Disorder: A Pilot Study.

Authors:  Ambra Stefani; David Gabelia; Birgit Högl; Thomas Mitterling; Philipp Mahlknecht; Heike Stockner; Werner Poewe; Birgit Frauscher
Journal:  J Clin Sleep Med       Date:  2015-11-15       Impact factor: 4.062

5.  Family history of idiopathic REM behavior disorder: a multicenter case-control study.

Authors:  Yves Dauvilliers; Ronald B Postuma; Luigi Ferini-Strambi; Isabelle Arnulf; Birgit Högl; Raffaele Manni; Tomoyuki Miyamoto; Wolfgang Oertel; Maria Livia Fantini; Monica Puligheddu; Poul Jennum; Karel Sonka; Marco Zucconi; Smeranda Leu-Semenescu; Birgit Frauscher; Michele Terzaghi; Masayuki Miyamoto; Marcus Unger; Alex Desautels; Christina Wolfson; Amélie Pelletier; Jacques Montplaisir
Journal:  Neurology       Date:  2013-05-08       Impact factor: 9.910

6.  Sleep: First study of risk factors for REM sleep behaviour disorder uncovers a few surprises.

Authors:  Katie Kingwell
Journal:  Nat Rev Neurol       Date:  2012-07-17       Impact factor: 42.937

Review 7.  Parkinson's disease and sleep/wake disturbances.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Koichi Hirata
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

8.  Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Josie-Anne Bertrand; Daphné Génier Marchand; Jacques Y Montplaisir
Journal:  Neurology       Date:  2015-02-13       Impact factor: 9.910

9.  Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study.

Authors:  Ronald B Postuma; Alex Iranzo; Birgit Hogl; Isabelle Arnulf; Luigi Ferini-Strambi; Raffaele Manni; Tomoyuki Miyamoto; Wolfgang Oertel; Yves Dauvilliers; Yo-El Ju; Monica Puligheddu; Karel Sonka; Amelie Pelletier; Juan Santamaria; Birgit Frauscher; Smaranda Leu-Semenescu; Marco Zucconi; Michele Terzaghi; Masayuki Miyamoto; Marcus M Unger; Bertrand Carlander; Maria-Livia Fantini; Jacques Y Montplaisir
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

10.  Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study.

Authors:  Birgit Frauscher; Poul Jennum; Yo-El S Ju; Ronald B Postuma; Isabelle Arnulf; Valerie Cochen De Cock; Yves Dauvilliers; Maria L Fantini; Luigi Ferini-Strambi; David Gabelia; Alex Iranzo; Smaranda Leu-Semenescu; Thomas Mitterling; Masayuki Miyamoto; Tomoyuki Miyamoto; Jacques Y Montplaisir; Wolfgang Oertel; Amélie Pelletier; Paolo Prunetti; Monica Puligheddu; Joan Santamaria; Karel Sonka; Marcus Unger; Christina Wolfson; Marco Zucconi; Michele Terzaghi; Birgit Högl; Geert Mayer; Raffaele Manni
Journal:  Neurology       Date:  2014-02-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.